Back to search results

Suramin for the Treatment of Autism Trial: KZ101 in a Male Pediatric Population With Autism Spectrum Disorder (ASD)

Abroad (travel likely)RecruitingPHASE2

Conditions

Autism Spectrum Disorder (ASD)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Southwest Autism Research and Resource Center, Phoenix, Arizona, United States

    Contact: Study coordinator (Padmaja Lakamsani) · PLakamsani@autismcenter.org · 602-340-8717
    Contact: Principal Investigator (Christopher J Smith, PhD)

  • Children's Hospital Orange County, Thompson Autism and Neurodevelopmental Center, Orange, California, United States

    Contact: Study coordinator (Adrienne R Moore, PhD) · adrienne.moore@choc.org · 714-288-7456
    Contact: Principal Investigator (Aram Kim, MD)

  • Kennedy Krieger Institute, Baltimore, Maryland, United States

    Contact: Study coordinator (Katie Kay) · kayk@kennedykrieger.org · 443-923-3819
    Contact: Study coordinator (Karen Chen) · chenk@kennedykrieger.org · 667-205-4393
    Contact: Principal Investigator (Stephanie Morris, MD)
Study leads

  • Aram Kim, MD

    Principal Investigator

    Thompson Autism and Neurodevelopmental Center, Children's Hospital of Orange County

View source on ClinicalTrials.gov(opens in a new tab)